John Vavricka - Net Worth and Insider Trading
John Vavricka Net Worth
The estimated net worth of John Vavricka is at least $382,805 dollars as of 2024-09-20. John Vavricka is the Chief Commercial Officer of Atea Pharmaceuticals Inc and owns about 104,023 shares of Atea Pharmaceuticals Inc (AVIR) stock worth over $382,805. Details can be seen in John Vavricka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Vavricka has not made any transactions after 2024-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Vavricka
John Vavricka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Vavricka owns 1 companies in total, including Atea Pharmaceuticals Inc (AVIR) .
Click here to see the complete history of John Vavricka’s form 4 insider trades.
Insider Ownership Summary of John Vavricka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVIR | Atea Pharmaceuticals Inc | 2024-02-01 | Chief Commercial Officer |
John Vavricka Latest Holdings Summary
John Vavricka currently owns a total of 1 stock. John Vavricka owns 104,023 shares of Atea Pharmaceuticals Inc (AVIR) as of February 1, 2024, with a value of $382,805.
Latest Holdings of John Vavricka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals Inc | 2024-02-01 | 104,023 | 3.68 | 382,805 |
Holding Weightings of John Vavricka
John Vavricka Form 4 Trading Tracker
According to the SEC Form 4 filings, John Vavricka has made a total of 1 transactions in Atea Pharmaceuticals Inc (AVIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Atea Pharmaceuticals Inc is the sale of 11,819 shares on February 1, 2024, which brought John Vavricka around $45,385.
Insider Trading History of John Vavricka
- 1
John Vavricka Trading Performance
John Vavricka Ownership Network
John Vavricka Owned Company Details
What does Atea Pharmaceuticals Inc do?
Who are the key executives at Atea Pharmaceuticals Inc?
John Vavricka is the Chief Commercial Officer of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi , See Remarks Andrea Corcoran , and See Remarks Wayne Foster .
Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary
Over the past 18 months, John Vavricka made 1 insider transaction in Atea Pharmaceuticals Inc (AVIR) with a net sale of 11,819. Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 17,544 shares made by Bruce Polsky , and a net sale of 15,870 shares made by Maria Arantxa Horga .
In summary, during the past 3 months, insiders sold 57,969 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 57,969 shares. During the past 18 months, 203,467 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,467 shares.
Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atea Pharmaceuticals Inc Insider Transactions
John Vavricka Mailing Address
Above is the net worth, insider trading, and ownership report for John Vavricka. You might contact John Vavricka via mailing address: C/o Atea Pharmaceuticals, Inc., 125 Summer Street, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
